1 Min Read
Dec 13 (Reuters) - Actinium Pharmaceuticals Inc
* Actinium Pharmaceuticals announces submission of EU Orphan Designation application for Actimab-A Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.